Coronavirus Treatment Updates

There was a bit of news on each of three coronavirus treatment fronts this week: hydroxychloroquine, convalescent plasma, and Remdesivir. Remmdesivir At the end of April, the NIH announced that Remdesivir helps people hospitalized with COVID-19 recover a bit faster. They didn't actually share many details in their press release. Now, the peer-reviewed paper with … Continue reading Coronavirus Treatment Updates

Over 99% of Mild COVID-19 Patients Develop Antibodies

A new study, doctors from the Icahn School of Medicine tested for antibodies in over 1,000 patients who had recovered from mild cases of COVID-19. On a first test, they found that 89% of them had antibodies. Two weeks later, they re-tested about two-thirds of the patients who had tested negative. With the additional time, … Continue reading Over 99% of Mild COVID-19 Patients Develop Antibodies

Estimating the number of SARS-CoV-2 infections in the United States

[Update from 4/19/20] Our preprint became available on medRxiv a few days ago here. We've also updated the model with data through April 18th. Abstract  We apply a model developed by The COVID-19 Response Team [S. Flaxman, S. Mishra, A. Gandy, et al., “Estimating the number of infections and the impact of non- pharmaceutical interventions … Continue reading Estimating the number of SARS-CoV-2 infections in the United States